A Phase 1 Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2018
At a glance
- Drugs SRF 231 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Adverse reactions; First in man
- Sponsors Surface Oncology
- 29 May 2018 According to a Surface Oncology media release, initial clinical results from this trial are expected in the first half of 2019.
- 26 Mar 2018 New trial record
- 20 Mar 2018 According to a Surface Oncology media release, the first patient was treated in this phase I trial.